-
Human Bone Marrow CD34+ Progenitor Cells, Cryopreserved, 500,000Catalog #: 2M-101B
Bone Marrow CD34 Cells+, 500,000 cells, cryopreserved, isolated from mononuclear cells using positive immunomagnetic selection
Sales unit: each -
Human Bone Marrow CD34+ Progenitor Cells, Cryopreserved, 300,000Catalog #: 2M-101A
Bone Marrow CD34+ Cells, 300,000 cells, cryopreserved, positively selected
Sales unit: each -
NK - Human Natural Killer Cells, Cryopreserved, Negative Selection, 5 MillionCatalog #: 2W-501
Crypreserved ampule of Peripheral Blood Human Natural Killer Cells (CD56 negative immunomagnetic selection) containing ≥ 5 million cells
Sales unit: each -
Human Bone Marrow CD34+ Progenitor Cells, Cryopreserved, 2 MillionCatalog #: 2M-101D
Bone Marrow CD34+ Cells, ≥2 million cells, cryopreserved, positively selected
Sales unit: each -
Human Bone Marrow Mononuclear CellsCatalog #: 1M-125CBone Marrow Mononucl. Cells, 25 million cellsSales unit: each
-
Human Bone Marrow Mononuclear CellsCatalog #: 1M-125EBone Marrow Mononucl. Cells, 300 million cellsSales unit: each
-
TheraPEAK® T-VIVO® Cell Culture Medium 1L bagCatalog #: BP08-970Y
TheraPEAK® T-VIVO® Cell Culture Medium, chemically defined, non-animal origin (NAO), serum-free, with recombinant proteins, 1 L bag
Sales unit: Bag -
TheraPEAK® T-VIVO® Cell Culture Medium 1L bottleCatalog #: BP12-970Q
TheraPEAK® T-VIVO® Cell Culture Medium, chemically defined, non-animal origin (NAO), serum-free, with recombinant proteins, 1 L bottle
Sales unit: Bottle -
Cryo Human Leukopak (9.5 Billion Cells)Catalog #: 260240.01
Cryopreserved human leukapheresis product (≥9.5 billion cells)
Sales unit: Bag -
Cryo Human Leukopak (5.0 Billion Cells)Catalog #: 260260.01
Cryopreserved human leukapheresis product (≥5.0 billion cells)
Sales unit: Bag
-
Cryopreservation of Peripheral Blood Mononuclear CellsDoes Not Alter Immune Cell Phenotype
-
Predicting Antibody Dependent Cell-Mediated Cytotoxicity (ADCC)Genotypic and Phenotypic Screening of Human Peripheral Blood Mononuclear Cells
-
Two Distinct Activation Methods Yield Clinical-Scale Expansion of Peripheral Blood Derived γδ T CellsIn this study, we demonstrate that billions of γδ T cells can be generated from peripheral blood mononuclear cells (PBMCs) with two distinct activation methods, using TheraPEAK® T-VIVO® Medium.
-
Normal Peripheral Blood CD4+ T LymphocytesLonza Application Notes
-
B-ALI Immune-Airway Co-Culture Model: Normal Human Bronchial Epithelial cells and Peripheral Blood Mononuclear Cells - Instructions for useProtocol to culture B-ALI NHBE cells with PBMCs
-
Validation of Th17 Cell Differentiation from Peripheral BloodLonza White Paper
-
siRNA Transfection Protocol for Blood LymphocytesInstructions of use for transfection of human peripheral blood lympohocytes with siRNA using the Nucleofector™ Technology
-
Transfection Protocol for Human T Cells (Stim.) - HT Nucleofector™ DeviceInstructions of use for transfection of stimulated peripheral blood human T cells with the P3 Primary Cell HT-Nucleofector™ Kit
-
Tips For Optimizing Your CD8+ T Cell and Dendritic Cell Co-culturesA co-culture between matured dendritic cells (DCs) and CD8+ T cells isolated from Lonza cryopreserved human peripheral blood mononuclear cells (PBMCs; part nos. CC-2702 – CC-2705) and we present three major takeaways from this process that are critical for successful co-culture and end-point analysis for these two cell types
-
Transfection Protocol for Human T Cells (Stim.) - 96-well Shuttle™ DeviceInstructions of use for transfection of stimulated peripheral blood human T cells with the P3 Primary Cell 96-well Nucleofector™ Kit